DURVASCC: New Phase II Trial for EPSCC
In a groundbreaking phase II clinical trial, researchers are exploring an innovative therapeutic strategy for extensive-stage extrapulmonary small cell carcinoma ...
In a groundbreaking phase II clinical trial, researchers are exploring an innovative therapeutic strategy for extensive-stage extrapulmonary small cell carcinoma ...
A groundbreaking study conducted by researchers at the University of California San Diego has unveiled compelling evidence suggesting that glucagon-like ...
In the ever-evolving landscape of cancer research, a groundbreaking study has emerged that promises to reshape our understanding of multiple ...
In a groundbreaking study published in BMC Cancer, researchers have unveiled a novel molecular mechanism that undermines the metabolic resilience ...
In an era where the fight against esophageal squamous cell carcinoma (ESCC) remains a formidable challenge, a newly published phase ...
In a groundbreaking exploration that bridges cellular biology with neuroscience, a UC Merced molecular and cell biologist has uncovered intriguing ...
In an era where medical science is forging new pathways in understanding diseases and treatment strategies, recent research has unveiled ...
Recent advancements in the realm of precision medicine have brought to light the complexities surrounding the treatment of chronic myeloid ...
At the recent European Society for Medical Oncology (ESMO) Congress 2025 held in Berlin, researchers from Memorial Sloan Kettering Cancer ...
A groundbreaking phase II clinical trial named AXIOM is set to explore an innovative combination of stereotactic body radiotherapy (SBRT) ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine